Print this page Email this page
Users Online: 397
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 
REVIEW ARTICLE
Year : 2013  |  Volume : 27  |  Issue : 2  |  Page : 90-93

Linaclotide: A novel intestinal secretagogue for treating chronic constipation and constipation predominant irritable bowel syndrome


Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh, India

Correspondence Address:
Ruchika Nandha
Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Sector 25, Chandigarh - 160 014
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-4958.121571

Rights and Permissions

Chronic constipation and constipation-predominant irritable bowel syndrome with constipation (IBS-C) are the common functional gastrointestinal problems which affect millions of people worldwide leading to increased health-care costs and impaired quality of life. Existing treatments have not been able to produce satisfactory results in 50% of the patient population. Drugs such as Tegaserod and Lubiprostone were also not clinically preferred because of cardiovascular adverse effects with the former and severe nausea causing intolerance with the later. Linaclotide is a first in class guanylate cyclase type-C receptor agonist, which has not only been found to be efficacious and safe for the treatment of chronic constipation and IBS-C but also has a positive impact on quality of life as demonstrated in placebo controlled clinical trials, with diarrhea as the most common adverse effect. This novel agent has recently been approved on 30 th August 2012 for clinical use in patients of more than 16 years of age.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2079    
    Printed32    
    Emailed1    
    PDF Downloaded192    
    Comments [Add]    

Recommend this journal